RareCyte

Seattle, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

$20.0M raised

Jun 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has RareCyte raised?

RareCyte has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.

Who are RareCyte's investors?

RareCyte's investors include Arboretum Ventures, 5AM Ventures, Agilent Technologies, HealthQuest Capital, The Forest Road Company.

Where is RareCyte headquartered?

RareCyte is headquartered in Seattle, United States.

What does RareCyte do?

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

What stage is RareCyte at?

RareCyte is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 27, 2024.

MLA

"RareCyte — Funding & Investors." VCBacked, June 27, 2024, https://www.vcbacked.co/company/rarecyte. Accessed July 3, 2026.

APA

VCBacked. (2024). RareCyte — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/rarecyte

Wikipedia (cite web)

{{cite web |title=RareCyte — Funding & Investors |url=https://www.vcbacked.co/company/rarecyte |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 27, 2024.